YOUR BUSINESS AUTHORITY
Springfield, MO
Generic drug manufacturer Mallinckrodt Pharmaceuticals reached a tentative deal to settle opioid claims.
Through the deal, Mallinckrodt would pay a $1.6 billion settlement and enter its generics business into Chapter 11 bankruptcy.
The settlement comes amid thousands of lawsuits in a federal case that seeks to determine who should be held financially liable for the impact of the opioid crisis.
Read more from The Washington Post.
Organizers hope to bolster client traffic to center city businesses.
SBJ announces executive newsroom hires
Timeshare exit company owner sentenced for tax evasion
State awards Springfield $4.6M for wastewater system improvements
Stockton district names next superintendent
Trump, fast-food companies among targets of X redirects
Council modifies data center definitions bill, extends moratorium into next year